Last reviewed · How we verify
NCT05232799
Care Anywhere With Community Paramedics Program to Reduce Hospitalization
NA trial testing Care Anywhere with Community Paramedics program in Acute Illness in 250 participants. Completed in 31 March 2023.
31 March 2023
Quick facts
| Lead sponsor | Mayo Clinic |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 250 |
| Start date | 21 January 2022 |
| Primary completion | 31 March 2023 |
| Estimated completion | 31 March 2023 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Care Anywhere with Community Paramedics program
Conditions studied
- Acute Illness — all drugs for Acute Illness →
Sponsor
Mayo Clinic
Who can join
18 and older, any sex, with Acute Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research is to compare the effectiveness of the Care Anywhere with Community Paramedics program with usual care in a pragmatic randomized controlled trial. The goal of the Care Anywhere with Community Paramedics program is to prevent or shorten hospitalizations among patients who are being treated in the clinic/ambulatory setting ("prehospital setting"), emergency department, or hospital and are clinically appropriate to be cared for at home with community paramedic services.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Community paramedic hospital reduction and mitigation program: study protocol for a randomized pragmatic clinical trial.
Ridgeway JL, Gerdes EOW, Dodge A, Liedl CP, et al · · 2023 · cited 5× · PMID 36805692 · DOI 10.1186/s13063-022-07034-w -
Proceedings of the 6th UK and Ireland implementation science research conference.
· 2024 · cited 2× · PMID 38504346 · DOI 10.1186/s13012-024-01341-3 -
Exploring implementation and sustainability of a community paramedicine model to reduce hospitalizations: a pragmatic randomized trial.
Ridgeway JL, Lampman MA, Haugo OA, Glasgow A, et al · · 2026 · PMID 41992204 · DOI 10.1186/s12913-026-14532-z -
Evaluating adoption and reach in a pragmatic randomized trial of community paramedicine for intermediate acuity patient care.
Ridgeway JL, Sundt WJS, Krpata TS, Glasgow A, et al · · 2024 · PMID 39655042 · DOI 10.1017/cts.2024.646
Verify or expand the search:
- PubMed search for NCT05232799
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Illness
Currently open trials in the same condition.
- NCT05782855 — ROBot Assisted Physical Training of Older Patients During acUte hospitaliSaTion · NA · active not recruiting
Other Mayo Clinic trials
Trials by the same sponsor.
- NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
- NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
- NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
- NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05232799 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
- Last refreshed: 5 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05232799.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing